Eye Care

The Pharmacy Times® Eye Care resource center provides clinical news and articles, coverage from ophthalmology conferences and meetings, links to condition-specific resources, and videos and other content.

What can we help you find?
[[thumbnail_alt_text]]
Seventeen states with medical marijuana laws saved Medicare Part D approximately $165.2 million in 2013.
 
[[thumbnail_alt_text]]
Medicated ring shows better adherence rate and decreased eye pressure in patients with glaucoma or ocular hypertension.
 
[[thumbnail_alt_text]]
Slow-binding inhibitors of cholinesterases could produce treatments for Alzheimer's disease, myasthenia, and neuroprotection.
[[thumbnail_alt_text]]
Metformin use is associated with a reduced risk of glaucoma development among diabetics.
[[thumbnail_alt_text]]
Glaucoma patients typically have ever-changing drug therapy regimens involving multiple eye drop products.
[[thumbnail_alt_text]]
The FDA is reviewing a novel treatment for patients with open angle glaucoma or ocular hypertension.
[[thumbnail_alt_text]]
Early detection and treatment are key to protecting eyesight.
[[thumbnail_alt_text]]
This continuing education activity is supported by an unrestricted educational grant from Alcon, Inc.
[[thumbnail_alt_text]]
Switching patients with glaucoma to generic medications can improve their adherence to ophthalmic drug therapies, according to researchers from the University of Michigan Kellogg Eye Center and College of Pharmacy.
[[thumbnail_alt_text]]
Latanoprost eye drops may significantly reduce the risk of vision loss in patients with glaucoma.
[[thumbnail_alt_text]]
Latanoprostene bunod (Vesneo) demonstrated noninferiority to timolol maleate (Timoptic 5%) in pivotal Phase 3 studies.